100 related articles for article (PubMed ID: 20027017)
1. Is PSA necessary after prostatectomy?
Kessenich CR
Nurse Pract; 2010 Jan; 35(1):10-1. PubMed ID: 20027017
[No Abstract] [Full Text] [Related]
2. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
Trinkler F; Hauri D
Helv Chir Acta; 1994 Dec; 60(6):1081-5. PubMed ID: 7533147
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
4. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
5. [PSA kinetics after total prostatectomy].
Riedinger JM; Eche N; Fulla Y; Thuillier F
Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884
[TBL] [Abstract][Full Text] [Related]
6. [Is radical prostatectomy a suitable model for determination of PSA half-life?].
Brändle E; Gottfried HW; Maier S; Flohr P; Steinbach G; Hautmann RE
Urologe A; 1995 Sep; 34(5):419-23. PubMed ID: 7483161
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor biomarkers as predictors of serum PSA recurrence after radical prostatectomy.
de la Taille A; Buttyan R; Benson MC; Katz AE
Semin Urol Oncol; 1998 Aug; 16(3):137-44. PubMed ID: 9741418
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy].
Kinoshita H; Kamoto T; Mitsumori M; Kiyokawa T; Habuchi T; Kakehi Y; Hiraoka M; Ogawa O
Gan To Kagaku Ryoho; 2003 Jan; 30(1):32-7. PubMed ID: 12557702
[TBL] [Abstract][Full Text] [Related]
9. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach.
Salomon L; Levrel O; Anastasiadis AG; Saint F; de La Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC
Prostate Cancer Prostatic Dis; 2002; 5(4):285-90. PubMed ID: 12627213
[TBL] [Abstract][Full Text] [Related]
10. Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?
Grubb RL; Andriole GL
Nat Clin Pract Urol; 2006 Jun; 3(6):306-7. PubMed ID: 16763640
[No Abstract] [Full Text] [Related]
11. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
12. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
[TBL] [Abstract][Full Text] [Related]
13. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
[TBL] [Abstract][Full Text] [Related]
15. [Rising Prostate Specific Antigen following treatment with curative intention].
Jakobsen H; Pedersen KV
Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
[TBL] [Abstract][Full Text] [Related]
16. [Advanced prostate cancer with normal serum prostate-specific antigen values].
Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A
Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099
[TBL] [Abstract][Full Text] [Related]
17. Inadequacy of prostate-specific antigen doubling time estimates calculated using an ultrasensitive assay of prostate-specific antigen for biochemical failure after radical prostatectomy.
Shimizu F; Matsuyama Y; Tominaga T; Ohashi Y; Fujime M
Urol Int; 2007; 79(4):356-60. PubMed ID: 18025856
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
19. [PSA follow-up after radical prostatectomy].
Egawa S; Baba S
Nihon Rinsho; 2002 Dec; 60 Suppl 11():284-8. PubMed ID: 12599586
[No Abstract] [Full Text] [Related]
20. Introduction: rising PSA after radical prostatectomy: a burning issue.
Boccon-Gibod L
Semin Urol Oncol; 1999 Aug; 17(3):125-6. PubMed ID: 10462313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
